Practice
For the full versions of these articles see bmj.com was self limiting in 40-50% of cases. Polyarticular onset and small joint involvement (box) consistently predicted an unfavourable outcome. [2] [3] [4] Full blood count, erythrocyte sedimentation rate, C reactive protein, and anticyclic citrullinated peptide (anti-CCP) (or rheumatoid factor) help in confirming a diagnosis of rheumatoid arthritis and indicating the likely prognosis. Other antibodies such as antinuclear antibody and extractable nuclear antibodies were not indicated in the initial investigations of our patient as she had no sicca symptoms (dry eyes and mouth), hair loss, malar rash, photosensitivity, or Raynaud's phenomenon to suggest conditions such as systemic lupus erythematosus and S jögren's syndrome. Radiography of hands and feet may aid diagnosis by showing erosion or narrowing of joint spaces but is often normal and should not delay urgent referral of patients to a rheumatologist when inflammatory arthritis is suspected. If radiographic change is already evident at presentation, the prognosis is likely to be poor.
C reactive protein or erythrocyte sedimentation rate C reactive protein and erythrocyte sedimentation rate can be raised in inflammatory arthritis. The degree of increase is highly variable and can be absent in about 40% of patients with recent onset disease 6 and would not exclude the diagnosis of rheumatoid arthritis. Where the erythrocyte sedimentation rate is >100 mm/h or the C reactive protein is >120 mg/l, other diagnoses such as infection, vasculitis, or crystal arthritis need to be considered. In patients with raised acute phase proteins, the full blood count may also show a mild normochromic normocytic anaemia (haemoglobin concentration 90-110 g/l) and increased platelet count.
Rheumatoid factor or anti-CCP
A strongly positive rheumatoid factor increases the likelihood of early rheumatoid arthritis-particularly in patients with a polyarticular onset of arthritis-and A 32 year old woman presents to her general practitioner with a month's history of painful wrists and feet and increased tiredness, which she attributes to carrying and looking after her 6 month old son. When asked, she describes early morning stiffness for an hour and finds that over the counter ibuprofen eases the pain. She has no clinically significant history, such as psoriasis, recent infection, or diarrhoea. On examination, she has mildly swollen wrists and tenderness on compression of her metatarsophalyngeal joints.
What are the next investigations?
Given the polyarticular joint involvement, morning stiffness, and response to anti-inflammatory agents in our patient, inflammatory arthritis needs to be considered, although the course of early inflammatory arthritis is highly variable. In a prospective population based study in Sweden, 151 new cases of recent onset undifferentiated inflammatory arthritis were identified over a period of one year. When reviewed a year later, 21% of these patients had a diagnosis of rheumatoid arthritis, 36% still had undifferentiated arthritis, 24% reactive arthritis, and 7% psoriatic arthritis.
1 In other studies of recent onset undifferentiated arthritis, the arthritis progressed to rheumatoid arthritis at one year in a third of cases and
learning Points
Patients with polyarticular joint symptoms need urgent referral to a rheumatologist without awaiting radiography results Positive anticyclic citrullinated peptide (anti-CCP) antibodies have greater specificity than rheumatoid factor for rheumatoid arthritis, although at high titre both suggest an unfavourable outcome Radiographic changes are often seen late in rheumatoid arthritis; high resolution Doppler ultrasound or magnetic resonance imaging aid early diagnosis The classification criteria for rheumatoid arthritis are unhelpful in the early stages of the disease, but the need for disease modifying antirheumatic drugs can be accurately predicted by clinical and laboratory factors at presentation and US 13 guidelines. The advent of anti-tumour necrosis factor and other biological agents has made it possible to treat rheumatoid arthritis so effectively that remission or low disease activity within three to six months is an achievable goal in many patients with rheumatoid arthritis.
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Provenance and peer review: Commissioned; externally peer reviewed. correlates with a less favourable outcome. 2 5 Rheumatoid factor is absent in 38% of patients with rheumatoid arthritis 6 and can be falsely positive in many other conditions, such as lupus, Sjögren's syndrome, acute and chronic infections, cryoglobulinaemia, and lymphoproliferative disorders. It is also found in 1-2% of healthy individuals, increasing to 20% over the age of 65. Anti-CCP is an antibody with greater specificity than rheumatoid factor for rheumatoid arthritis, and, if available, should be requested in preference to it. Anti-CCP is particularly useful in patients negative for rheumatoid factor where rheumatoid arthritis is suspected. Anti-CCP has consistently been shown to be the strongest independent predictor of radiographic progression (odds ratio 4.0; 95% confidence interval 1.6 to 10.0) especially at higher titres (>200 U/ml). Rheumatoid factor has also shown a clear correlation with radiological damage (odds ratio 3.1; 1.2 to 7.9). 5 outcome Given the suggestive clinical features in our case scenario, the general practitioner referred the patient urgently to the rheumatology department, despite normal full blood count, erythrocyte sedimentation rate, C reactive protein, rheumatoid factor, and x ray films of hands and feet. The patient had further investigations, which showed strongly positive anti-CCP antibodies (>600 U/ml) and active synovitis without erosion on high resolution ultrasound scanning of her wrists using colour flow Doppler. Magnetic resonance imaging would have been a useful alternative investigation to identify synovitis, soft tissue abnormality, bone oedema, and joint erosion-many months before any changes would have been detected on plain radiographs. 7 The additional tests in our rheumatology department confirmed a diagnosis of rheumatoid arthritis in this patient, and as she was not breastfeeding or considering future pregnancy, treatment with disease modifying antirheumatic drugs was started, in accordance with recommendations for England, Wales, and Northern Ireland from the National Institute for Health and Clinical Excellence (NICE).
8
Rheumatoid arthritis affects 29 women and 18 men per 100 000 people a year in Sweden 1 and similar numbers of patients in the United Kingdom. 9 The cause of the disease is unknown, but genetic and environmental factors are considered important. Onset is usually gradual but needs to be differentiated from self limiting diseases as early as possible to ensure that patients at high risk of joint damage are seen early, given the growing evidence that early therapeutic intervention improves control and reduces joint damage 10 ; it is also important to differentiate rheumatoid arthritis from self limiting arthropathies to avoid unnecessary use of potentially toxic treatments.
The formal diagnostic criteria for rheumatoid arthritis 11 perform very poorly in early disease and cannot be used for therapeutic decision making. However, prospective studies have identified factors associated with an unfavourable outcome (box) 2-5 that can be used to support the need for urgent referral to a rheumatologist and treatment with disease modifying antirheumatic drugs
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• Disability related to COPD can be poorly reflected in the FEV 1 . A more comprehensive assessment of severity includes the degree of airflow obstruction
Over three million people in the United Kingdom are estimated to have chronic obstructive pulmonary disease (COPD), of whom more than two million remain undiagnosed, representing the so called "missing millions" alluded to in the draft national strategy for COPD.
1-3
This article summarises the most recent recommendations from the National Institute for Health and Clinical Excellence (NICE) on the management of stable chronic obstructive pulmonary disease in primary and secondary care, 4 which update the COPD guidelines first published by NICE in 2004.
5 The summary contains the most important recommendations relating to new diagnostic cr iteria for COPD, changes to the classification of severity of airflow obstruction, the need for multidimensional severity assessment, a new algorithm for inhaled drug treatments (figure), and the value of early pulmonary rehabilitation. 
recommendations

overcoming barriers
Age related interpretation of spirometry and its relation to clinical severity assessment may be a challenge for some non-specialists; this will require education and training. Measurement of post-bronchodilator spirometry is likely to result in minimal increase in resource use as reversibility testing (which is not recommended in the guideline) is currently undertaken to fulfil Quality Outcome Framework criteria. Realigning severity of airflow obstruction to agree with other international guidelines will lead to some patients having their severity stage reclassified; patients will need reassurance that their clinical condition, need for appropriate treatment, and prognosis all remain unchanged. 6 7 There is a potential economic impact of stronger new recommendations on (BMJ 2010; 340:c3209) Diagnosis and Ж clinical management of alcohol related physical complications (BMJ 2010; 340:c2942) Diagnosis and Ж management of idiopathic childhood constipation (BMJ 2010; 340:c2585) Pharmacological Ж management of neuropathic pain in nonspecialist settings (BMJ 2010; 340:c1079) inhaled therapies. In people with mild COPD the primary course of action is to encourage smoking cessation. Other treatments, recommended only when symptoms persist and/or when needed to prevent exacerbations, become more cost effective as the severity of disease progresses.
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